home / stock / bway / bway news

BWAY News and Press, BrainsWay Ltd. From 09/12/19

Stock Information
Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com
Menu
BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...
BWAY - Square Medical Group is Now Offering Mental Health Technology for Major Depressive Disorder (MDD) in Offices Across Massachusetts

DANVERS, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Square Medical Group , an integrated, multidisciplinary private group practice providing a full-range of outpatient mental health and chemical dependency services, is now offering BrainsWay ’s Deep Transcranial Magnetic Stimulation...
BWAY - Catalyst Psychiatry Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Corvallis

CORVALLIS, Ore., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Catalyst Psychiatry , a provider of mental health services in Oregon, is now offering BrainsWay ’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for patients with Major Depressive Disorder (MDD) and Obsessive-Compu...

BWAY - Brainsway Ltd. (BWAY) CEO Yaacov Michlin on Q2 2019 Results - Earnings Call Transcript

Brainsway Ltd. (BWAY) Q2 2019 Earnings Conference Call August 26, 2019 08:00 AM ET Company Participants Bob Yedid - LifeSci Advisors Yaacov Michlin - CEO Hadar Levy - CFO Conference Call Participants Craig Bijou - Cantor Fitzgerald Jayson Bedford - Raymond James & Ass...

BWAY - Brainsway +2% premarket on Q2 results

Brainsway ( BWAY ) Q2 results : Revenues: $5.7M (+54.1%). More news on: Brainsway Ltd., Healthcare stocks news, Earnings news and commentary, , Read more ...

BWAY - Brainsway EPS misses by $0.07, beats on revenue

Brainsway (NASDAQ: BWAY ): Q2 GAAP EPS of -$0.17 misses by $0.07 . More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

BWAY - Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights

JERUSALEM, Israel and HACKENSACK, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) (“Brainsway” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the ...

BWAY - BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019

JERUSALEM and HACKENSACK, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its second qu...
BWAY - New York Psychiatrist, Dr. Aleksandra Krunic, Introduces Groundbreaking FDA-Cleared Helmet to Treat Obsessive-Compulsive Disorder (OCD)

NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Dr. Aleksandra Krunic, head of Child and Adult Clinical Psychiatry New York, a top psychiatric clinic serving patients in Long Island and New York City with a variety of advanced treatments for mental health disorders, announced today that the com...

BWAY - NuMe TMS Clinics Now Offer FDA-Cleared Treatment for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Houston

HOUSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- NuMe TMS Clinics , a group of mental health clinics dedicated to serving its communities with safe and effective mental health treatments, today announced BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for both Majo...

BWAY - Achieve TMS East Celebrates the Opening of its Haverhill Location July 25, 2019

HAVERHILL, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of deep TMS therapy for the treatment of Depression and OCD, is pleased to announce the opening of its newest center in Haverhill, MA. Achieve TMS East will be celebrating the openin...
Previous 10 Next 10